Scarica l'app Stockscreener
1.716
0.00%
0.004
Precedente Chiudi:
$1.72
Aprire:
$1.72
Volume 24 ore:
65,299
Relative Volume:
0.11
Capitalizzazione di mercato:
$116.94M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-0.7981
EPS:
-2.15
Flusso di cassa netto:
$57,000
1 W Prestazione:
-8.99%
1M Prestazione:
-10.42%
6M Prestazione:
+38.71%
1 anno Prestazione:
-40.89%
Intervallo 1D:
$1.69
$1.735
Intervallo di 1 settimana:
$1.635
$1.89
Portata 52W:
$1.05
$3.21
Climb Bio Inc Stock (CLYM) Company Profile
Nome
Climb Bio Inc
Settore
Industria
Telefono
1-866-857-2596
Indirizzo
20 WILLIAM STREET, WELLESLEY HILLS
Confronta CLYM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.715 | 117.96M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.39 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.82 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.99 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.40 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.39 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Iniziato | William Blair | Outperform |
| 2025-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2025-08-15 | Iniziato | Robert W. Baird | Outperform |
| 2025-06-06 | Iniziato | Oppenheimer | Outperform |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Climb Bio Inc Borsa (CLYM) Ultime notizie
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - Setenews
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - Setenews
Can Climb Bio Inc. stock withstand economic slowdown2025 Dividend Review & Risk Managed Investment Strategies - Newser
Is Climb Bio Inc. stock a safe investment in uncertain marketsTrade Entry Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Climb Bio reports inducement grant under Nasdaq listing rule - MSN
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com
Brokerages Set Climb Bio, Inc. (NASDAQ:CLYM) Price Target at $9.20 - Defense World
Climb Bio (Nasdaq: CLYM) Announces Inducement Option for 120K Shares - Stock Titan
Climb Bio Inc (CLYM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Published on: 2025-11-19 22:13:39 - newser.com
Is Climb Bio Inc. stock a buy on dipsMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Climb Bio Inc. stock attractive after correctionQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Why Climb Bio Inc. stock is recommended by analystsInsider Selling & Accurate Buy Signal Alerts - newser.com
Predicting Climb Bio Inc. trend using moving averages2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Strategies to average down on Climb Bio Inc.2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Will Climb Bio Inc. stock go up soonRate Cut & High Win Rate Trade Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsForecast Cut & Stock Market Timing Techniques - newser.com
Momentum divergence signals in Climb Bio Inc. chart2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Has Climb Bio Inc. formed a bullish divergence2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Using R and stats models for Climb Bio Inc. forecastingJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Climb Bio, Inc. Reports Q3 2025 Financial Results - MSN
Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
What institutional flow reveals about Climb Bio Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Is Climb Bio Inc (CLYM) positioned for future growth? - Setenews
Applied Therapeutics Inc (APLT) expanding its growth trajectory ahead - setenews.com
Climb Bio Inc Azioni (CLYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Climb Bio Inc Azioni (CLYM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
0.04%
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):